Grant: Engage Grants Program
McMaster University
$24,972.00
Integration of cellular processing and nucleic acid detection devices for point of care detection of infectious diseases
EF 2013-14
Résumé
Infectious diseases are the leading cause of death in low-income countries. The Unavailability or limited availability of healthcare resources in low income countries including diagnostic systems, properly trained healthcare professionals, and therapeutics have contributed to the high infectious disease mortality rates in these regions. With the vision of creating rapid, inexpensive, portable, and easy-to-use diagnostic technologies, specially designed for use in low-income countries, a number of handheld disease diagnostic systems, based on electronic signal readout, have been developed and are at the early commercialization stages. These handheld systems work by identifying - in patient samples - the genetic code (DNA) of pathogens. In order for these DNA-detecting systems to be applicable to low-income settings, they often rely on additional systems for collecting patient samples and preparing them by methods such as heating, adding chemicals, and mechanical manipulation. DNA Genotek is an Ottawa-based company that has created a variety of kits for easy and rapid collection, preservation and preparation of bodily samples for diagnostic purposes. Due to the potential and rapid emergence of new handheld technologies for electronic DNA detection in low-income settings, DNA Genotek will work with the Soleymani research group to create a fully integrated sample preparation system specifically designed for such systems. This system will use reagents not causing interference with the electronic readout, will contain all the necessary reagents in a single kit, and will require no refrigeration, external power or additional instrumentation. This university-industry collaborative project will enable the creation of a Canadian product applicable to the five billion dollar DNA-based infectious disease diagnostic market.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
453249-2013
Name nom
Soleymani, Leyla
Department département
Engineering Physics
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2013
Award amount
24972
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Partie
1
Nb partie
1
Application title
Integration of cellular processing and nucleic acid detection devices for point of care detection of infectious diseases
Keyword
NSERC
Application summary
Infectious diseases are the leading cause of death in low-income countries. The Unavailability or limited availability of healthcare resources in low income countries including diagnostic systems, properly trained healthcare professionals, and therapeutics have contributed to the high infectious disease mortality rates in these regions. With the vision of creating rapid, inexpensive, portable, and easy-to-use diagnostic technologies, specially designed for use in low-income countries, a number of handheld disease diagnostic systems, based on electronic signal readout, have been developed and are at the early commercialization stages. These handheld systems work by identifying - in patient samples - the genetic code (DNA) of pathogens. In order for these DNA-detecting systems to be applicable to low-income settings, they often rely on additional systems for collecting patient samples and preparing them by methods such as heating, adding chemicals, and mechanical manipulation. DNA Genotek is an Ottawa-based company that has created a variety of kits for easy and rapid collection, preservation and preparation of bodily samples for diagnostic purposes. Due to the potential and rapid emergence of new handheld technologies for electronic DNA detection in low-income settings, DNA Genotek will work with the Soleymani research group to create a fully integrated sample preparation system specifically designed for such systems. This system will use reagents not causing interference with the electronic readout, will contain all the necessary reagents in a single kit, and will require no refrigeration, external power or additional instrumentation. This university-industry collaborative project will enable the creation of a Canadian product applicable to the five billion dollar DNA-based infectious disease diagnostic market.